Inventor
BRESLIN HENRY J
US22 patents
⚠️ This page may combine multiple inventors who share the name “BRESLIN HENRY J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
11 patentsUS7741356B2Jun 22, 2010
Compounds as opioid receptor modulators
JANSSEN PHARMACEUTICA NV38 citations96
US9700542B2Jul 11, 2017
Compounds as opioid receptor modulators
JANSSEN PHARMACEUTICA NV18 citations92
US8344011B2Jan 1, 2013
Compounds as opioid receptor modulators
JANSSEN PHARMACEUTICA NV17 citations92
US7786158B2Aug 31, 2010
Compounds as opioid receptor modulators
JANSSEN PHARMACEUTICA NV23 citations92
US5270464ADec 14, 1993
Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones
JANSSEN PHARMACEUTICA NV7 citations72
US7041681B2May 9, 2006
Compounds as opioid receptor modulators
JANSSEN PHARMACEUTICA NV3 citations63
US5371079ADec 6, 1994
Antiretroviral tetrahydroimidazo[1,4]benzodiazepin-2-(thi)ones
JANSSEN PHARMACEUTICA NV3 citations61
US10213415B2Feb 26, 2019
Compounds as opioid receptor modulators
JANSSEN PHARMACEUTICA NV0 citations52
US7659402B2Feb 9, 2010
Piperidines as opioid receptor modulators
JANSSEN PHARMACEUTICA NV0 citations52
US7202381B2Apr 10, 2007
Compounds as opioid receptor modulators
JANSSEN PHARMACEUTICA NV0 citations52
US8895573B2Nov 25, 2014
Phenoxy-substituted pyrimidines as opioid receptor modulators
JANSSEN PHARMACEUTICA NV1 citations51
JANNSEN PHARMACEUTICA N V
3 patentsUS9205076B2Dec 8, 2015
Compounds as opioid receptor modulators
JANNSEN PHARMACEUTICA N V12 citations92
US8772325B2Jul 8, 2014
Compounds as opioid receptor modulators
JANNSEN PHARMACEUTICA N V15 citations92
US8609709B2Dec 17, 2013
Compounds as opioid receptor modulators
JANNSEN PHARMACEUTICA N V11 citations92